Active substanceParacetamol + Phenylephrine + Pheniramine + Ascorbic acidParacetamol + Phenylephrine + Pheniramine + Ascorbic acid
Similar drugsTo uncover
  • GrippoFlu® for cold and flu
    powder inwards 
    MARBIOFARM, OJSC     Russia
  • MARBIOFARM, OJSC     Russia
  • Asterisk Fly
    powder inwards 
  • Maxikold® Reno
    powder inwards 
    OTISIFARM, OJSC     Russia
  • Stopgripan
    powder inwards 
    Alvogen IPKo S.A.L.     Luxembourg
  • Stopgripan forte
    powder inwards 
    Alvogen IPKo S.A.L.     Luxembourg
  • Dosage form: & nbspPowder for solution for oral administration
    Composition:One packet contains:

    Active ingredients: paracetamol 325 mg, phenylephrine hydrochloride 10 mg, phenylramine maleate 20 mg, ascorbic acid 50 mg.

    Auxiliary substances: sodium citrate dihydrate 120.74 mg, malic acid 50.31 mg, dye sunset yellow 0.098 mg, dye quinoline yellow 0.094 mg, titanium dioxide 3.16 mg, flavoring lemon 208.42 mg, calcium phosphate tribasic 82 mg , citric acid 1221.79 mg, sucrose 20,000 mg.

    Description:Loose white granular powder with yellow impregnations without foreign particles with citrus smell. Presence of soft lumps.
    Pharmacotherapeutic group:ARI and "colds" of symptoms remedy (analgesic non-narcotic means + alpha-adrenomimetic + H1-histamine receptor blocker + vitamin).
    ATX: & nbsp

    N.02.B.E   Anilides

    N.02.B.E.51   Paracetamol in combination with other drugs, excluding psycholeptics

    Pharmacodynamics:Combined drug, has antipyretic, anti-inflammatory, anti-edematous, analgesic, anti-allergic effect.

    Indications:Symptomatic treatment of infectious and inflammatory diseases (acute respiratory viral infection, including influenza) accompanied by fever, chills, body aches, headache and muscle pain, runny nose, stuffy nose, sneezing.

    Contraindications:Hypersensitivity to individual components of the drug, simultaneous administration of tricyclic antidepressants, monoamine oxidase inhibitors, beta-adrenoblockers, portal hypertension, alcoholism, sugarase / isomaltase deficiency, fructose intolerance, glucose-galactose maladsorption, pregnancy, breast-feeding period, children under 12 years.

    Carefully:With arterial hypertension, diabetes, closed-angle glaucoma,severe diseases of the liver or kidneys, lungs (including bronchial asthma), difficulty urinating with prostatic hyperplasia, blood diseases, congenital hyperbilirubinemia (Gilbert syndrome, Dubin-Johnson and Rotor syndrome), hyperthyroidism, pheochromocytoma. If you have any of these diseases, consult a doctor before taking the drug.

    Pregnancy and lactation:It is not recommended to use the drug during pregnancy and lactation because of the lack of data on the safe use of the drug in these individuals.
    Dosing and Administration:Inside. The contents of one sachet are dissolved in 1 glass of boiled hot water. Take in hot. You can add sugar to taste. Repeated dose can be taken every 4 hours (no more than 3 doses in 24 hours). TeraFlu® from flu and cold can be used at any time of the day, but the best effect comes from taking the drug before going to bed, at night. If, there is no relief of symptoms within 3 days after starting the drug, you should consult your doctor.

    Side effects:

    Possible allergic reactions (rash, itching, urticaria, angioedema),increased excitability, decreased speed of psychomotor reactions, fatigue, dry mouth, urinary retention, nausea, vomiting, stomach pain, palpitations, increased blood pressure, dizziness, sleep disturbances, mydriasis, paresis of accommodation, increased intraocular pressure. Given the presence of paracetamol: violations of the blood system (anemia, thrombocytopenia, leukopenia, agranulocytosis), with prolonged use of high doses are possible hepatotoxic and nephrotoxic effects, hemolytic anemia, methemoglobinemia, pancytopenia. If any of the side effects listed in the manual are aggravated, or if you notice any other side effects not listed in the instructions, tell your doctor.

    Overdose:Symptoms (due to paracetamol, manifested after taking more than 10-15 g): pallor of the skin, decreased appetite, nausea, vomiting, pain in the epigastric region, in severe cases - liver failure, hepatonecrosis, increased activity of "liver" transaminases, increased prothrombin time , encephalopathy and coma.

    Treatment: gastric lavage in the first 6 hours, administration of donors of SH-groups and precursors of glutathione -methionine synthesis 8-9 hours after an overdose and acetylcysteine ​​after 12 hours.
    Interaction:

    It is recommended to refrain from taking the drug when taking MAO inhibitors, sedatives, ethanol. The risk of hepatotoxic effects of paracetamol increases with the simultaneous use of barbiturates, phenytoin, carbamazepine, rifampicin, zidovudine, and other inducers of microsomal liver enzymes. Antidepressants, antiparkinsonian and antipsychotic agents, phenothiazine derivatives increase the risk of urinary retention, dry mouth, constipation. Glucocorticoids increase the risk of increased intraocular pressure. Paracetamol reduces the effectiveness of uricosuric drugs and improves the effectiveness of indirect anticoagulants. Tricyclic antidepressants strengthen the sympathomimetic effect, the simultaneous use of halothane increases the risk of ventricular arrhythmia. Phenylephrine reduces the hypotensive effect of guanethidine, which in turn enhances the alpha-adrenomimetic effect of phenylephrine.

    Ethanol can enhance the sedative effect of phenyramine.

    Special instructions:To avoid toxic damage to the liver, the drug should not be combined with the use of alcoholic beverages.

    When taking the drug is not recommended to drive or other mechanisms. Do not use the drug from damaged pouches.

    Form release / dosage:

    Powder for solution for ingestion [lemon].

    Packaging:

    For the factory Famar France, France:

    By 22.1 g of powder in a 5-layer sachet (paper / polyethylene / low density polyethylene / aluminum foil / low density polyethylene). By 1,2, 3, 4, 5, 6, 7, 8, 10, 12 or 25 bags in a cardboard box. Sachets can be placed individually or stapled in pairs. Instructions for use are applied to the sachet.

    Or by 1,2, 3, 4, 5, 6, 7, 8, 10, 12 or 25 bags in a cardboard box together with instructions for use. Sachets can be placed individually or stapled in pairs.

    For the factory of Famar Orleans, France:

    By 22.1 g of powder in a 4-layer sachet (polyethylene / polyethylene low density / aluminum foil / low density polyethylene) or a 5-layer sachet (paper / polyethylene / low-density polyethylene density / aluminum

    foil / low density polyethylene).1, 2, 3, 4, 5, 6, 7, 8, 10, 12 or 25 bags in a cardboard box. Sachets can be placed individually or stapled in pairs. Instructions for use are applied to the sachet.

    Or 1, 2, 3, 4, 5, 6, 7, 8, 10, 12 or 25 bags in a cardboard box together with instructions for use. Sachets can be placed individually or stapled in pairs.

    For Novartis Consumer Helms Inc., USA:

    By 22.1 g of powder in a 6-layer sachet (paper / low density polyethylene / polyethylene / low density polyethylene / aluminum foil / low density polyethylene). 1, 2, 3, 4, 5, 6, 7, 8, 10, 12 or 25 bags in a cardboard box. Sachets can be placed individually or stapled in pairs. Instructions for use are applied to the sachet.

    Or by 1,2, 3, 4, 5, 6, 7, 8, 10, 12 or 25 bags in a cardboard box together with instructions for use. Sachets can be placed individually or stapled in pairs.
    Storage conditions:At a temperature of no higher than 25 ° C.

    Keep out of the reach of children.

    Shelf life:2 years.

    The drug should not be used after the expiration date.
    Terms of leave from pharmacies:Without recipe
    Registration number:П N012063 / 01
    Date of registration:31.05.2011
    The owner of the registration certificate:Новартис Консьюмер Хелс САНовартис Консьюмер Хелс СА Switzerland
    Manufacturer: & nbsp
    Representation: & nbspNOVARTIS CONSUMER HELS S.A. (part of Novartis groups) NOVARTIS CONSUMER HELS S.A. (part of Novartis groups) Switzerland
    Information update date: & nbsp13.09.2012
    Illustrated instructions
      Instructions
      Up